Robin R. Chamberland, PhD D(ABMM)

Saint Louis University School of Medicine

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-763) Assessment of the in vitro potency of anti-mycobacterial agents against clinical Mycobacterium avium complex (MAC) pulmonary isolates: implications of intravenous and inhaled amikacin breakpoint reporting
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT